Search Results
- < Prev
1 of 1
- Next >
News Releases
-
May 21, 2013, 08:15 ET
Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine
Sanofi (EURONEXT: SAN and NYSE: SNY) and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the New England Journal of Medicine published online the positive Phase 2a study results of dupilumab (SAR231893/REGN668) in patients with moderate-to-severe allergic asthma....
More news about: Regeneron Pharmaceuticals, Inc. , New England Journal of Medicine , American Thoracic Society 2013 International Conference
-
May 16, 2013, 09:30 ET
The Zacks Analyst Blog Highlights: Genomic Health, Sanofi, Regeneron Pharmaceuticals, Amgen and Isis Pharmaceuticals
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Genomic Health Inc. (Nasdaq:GHDX), Sanofi (NYSE:SNY),...
More news about: Zacks Investment Research, Inc. , Genomic Health Inc. , Sanofi , Regeneron Pharmaceuticals, Inc. , Amgen Inc. , Isis Pharmaceuticals, Inc.
-
May 15, 2013, 09:31 ET
Critical Alerts For SanDisk, Computer Sciences, American Tower Corp, Questcor Pharmaceuticals, and Regeneron Pharmaceuticals Released By InvestorsObserver
InvestorsObserver issues critical PriceWatch Alerts for SNDK, CSC, AMT, QCOR, and REGN. (Logo: http://photos.prnewswire.com/prnh/20120712/CG39046) To see what our analysts have discovered about these stocks read the InvestorsObserver's PriceWatch Alerts at...
More news about: InvestorsObserver , SanDisk , Computer Sciences , American Tower Corp , Questcor Pharmaceuticals , Regeneron Pharmaceuticals
-
May 15, 2013, 01:00 ET
Sanofi and Regeneron Announce Patient Enrollment in Two Phase 3 Trials with Sarilumab in Rheumatoid Arthritis (RA)
Sanofi (EURONEXT: SAN and NYSE: SNY) and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the COMPARE and ASCERTAIN trials of sarilumab, the first fully human monoclonal antibody directed against the IL-6 receptor, which is delivered by subcutaneous injection every other...
More news about: Regeneron Pharmaceuticals, Inc. , Sanofi
-
May 08, 2013, 09:30 ET
Regeneron Announces Upcoming 2013 Investor Conference Presentations
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast management presentations at the following investor conferences: - UBS Global Healthcare Conference on Monday, May 20, 2013. The presentation is scheduled for 10:00 a.m. Eastern Time. - 38th Annual dbAccess...
More news about: Regeneron Pharmaceuticals, Inc.
-
May 03, 2013, 06:30 ET
Regeneron Reports First Quarter 2013 Financial and Operating Results
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced financial and operating results for the first quarter of 2013 and provided an update on development programs. The Company reported total revenues of $440 million in the first quarter of 2013, compared to $232 million in...
More news about: Regeneron Pharmaceuticals, Inc.
-
May 03, 2013, 06:30 ET
Regeneron Acquires Full Rights to Two Novel Ophthalmology Development Programs
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it has expanded its ophthalmology portfolio by acquiring full exclusive rights to two families of novel antibodies invented at Regeneron and previously included in Regeneron's antibody collaboration with Sanofi. ...
More news about: Regeneron Pharmaceuticals, Inc. , Sanofi
-
Apr 24, 2013, 18:18 ET
Regeneron Set to Join the S&P 500; Eagle Materials, CST Brands to Join the S&P MidCap 400; Francesca's, Northern Oil & Gas to Join the S&P SmallCap 600
S&P Dow Jones Indices will make the following changes to the S&P 500, S&P MidCap 400 and the S&P SmallCap 600 indices: - S&P MidCap 400 constituent Regeneron Pharmaceuticals Inc. (NASD:REGN) will replace MetroPCS Communications Inc. (NYSE:PCS) in the S&P 500,...
More news about: S&P Dow Jones Indices , Regeneron Pharmaceuticals Inc. , MetroPCS Communications Inc. , Eagle Materials Inc. , Francesca's Holdings Corp. , CST Brands Inc. , Northern Oil and Gas Inc. , The Dolan Co. , Valero Energy Corp. , The McGraw-Hill Companies
-
Apr 18, 2013, 09:30 ET
Regeneron Announces Upcoming 2013 Investor Conference Presentations
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast management presentations at the following investor conferences: - Baird's 2013 Growth Stock Conference on Wednesday, May 8, 2013. The presentation is scheduled for 10:45 a.m. Eastern Time (9:45 a.m. Central Time)....
More news about: Regeneron Pharmaceuticals, Inc.
-
Apr 11, 2013, 16:05 ET
Regeneron to Report First Quarter 2013 Financial and Operating Results and Host Conference Call and Webcast on May 3, 2013
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it will report its first quarter 2013 financial and operating results on Friday, May 3, 2013, before the U.S. financial markets open. The Company will host a conference call and simultaneous webcast at 8:30 AM Eastern...
More news about: Regeneron Pharmaceuticals, Inc.
-
Apr 04, 2013, 09:15 ET
BioMed Realty To Develop 297,000 Square Feet In New York Fully Leased To Regeneron Pharmaceuticals
BioMed Realty Trust, Inc. (NYSE: BMR) announced today that it will commence construction on two new buildings comprising approximately 297,000 square feet and a parking structure at The Landmark at Eastview in Tarrytown, New York, expanding the campus to approximately 1.4 million square...
More news about: BioMed Realty Trust, Inc. , Regeneron Pharmaceuticals, Inc.
-
Apr 04, 2013, 09:15 ET
Regeneron Pharmaceuticals Announces Expansion in New York's Hudson Valley
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the Company will expand the Regeneron corporate headquarters and laboratories in Westchester County and create more than 400 new high-skill jobs. Today's announcement further cements the reputation of the Hudson Valley as...
More news about: Regeneron Pharmaceuticals, Inc.
- < Prev
1 of 1
- Next >
Modify your Search
 |
Quickly search for PR Newswire releases by adding our plugin to your browser search |